Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK -rearranged NSCLC patient: a case report | BMC Cancer | Full Text

Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK -rearranged NSCLC patient: a case report | BMC Cancer | Full Text

Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report

Targeted therapies are a standard of care for first-line treatment of Anaplastic lymphoma kinase (ALK)-rearranged non small cell lung cancer (NSCLC). Giving the rapid pace of drug discovery and development in thi...

Authors:F. Guisier, N. Piton, M. Bellefleur, N. Delberghe, G. Avenel, E. Angot, O. Vittecoq, M. Ould-Slimane, H. Morisse-Pradier, M. Salaun and L. Thiberville

Citation:BMC Cancer 2020 20:14

Content type:Case report

Published on: 6 January 2020

• ViewFull Text
 
• ViewPDF